CHANGES IN NUTRITIONAL STATUS AND DIETARY INTAKE AMONG PATIENTS WITH UPPER GASTROINTESTINAL CANCER RECEIVING MULTIMODAL TREATMENT AT MILITARY HOSPITAL 175

Viet Canh DO1,2, Tien Manh DAO3, Duy Dong NGUYEN4, Duc Minh PHAM4
1 Military Hospital 13
2 Vietnam Military Medical University
3 Military Hospital 175, Ho Chi Minh City
4 Military Hospital 103, Vietnam Military Medical University

Main Article Content

Abstract

Aims: To describe longitudinal changes in nutritional status and dietary intake among patients with upper gastrointestinal cancer receiving multimodal treatment at Military Hospital 175.


Methods: A longitudinal observational study was conducted in 62 patients with esophageal or gastric cancer. Assessments were performed before treatment (T0), after 2 weeks (T1), after 1 month (T2), and after 3 months (T3). Nutritional status was evaluated using body weight, BMI, and the Patient-Generated Subjective Global Assessment (PG-SGA). Dietary intake was assessed using repeated 24-hour dietary recalls.


Results: The mean age was 62.7 ± 8.5 years; 91.9% were male, and 85.5% had stage III–IV disease. Body weight decreased significantly from 55.45 ± 10.30 kg at T0 to 51.43 ± 8.19 kg at T3, and BMI declined from 21.94 ± 4.07 to 20.34 ± 3.24 kg/m² (p=0.001). PG-SGA score increased from 8.66 ± 3.35 at T0 to 9.69 ± 2.85 at T1, then decreased to 6.43 ± 3.03 at T3 (p<0.001). Energy intake decreased at T1 and then partially recovered by T3, with a significant overall change over time (p=0.011). Protein and carbohydrate intake showed similar early declines followed by partial recovery, whereas lipid intake remained relatively stable.


Conclusion: Patients with upper gastrointestinal cancer experienced significant nutritional changes during the first three months of multimodal treatment. The early treatment phase, particularly the first two weeks, represents a vulnerable period for nutritional deterioration. Regular assessment using PG-SGA, anthropometric indicators, and dietary intake evaluation should be integrated into multimodal cancer care to support timely nutritional intervention.

Article Details

References

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2024 Apr 4;74(3):229–63. doi: 10.3322/caac.21834.
2. Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition. 2021 Mar;40(5): 2898-2913. doi: 10.1016/j.clnu.2021.02.005.
3. Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr, 2002. 56(8): 779-85. doi: 10.1038/sj.ejcn.1601412.
4. Shah MA, Kennedy EB, Catenacci DV, Deighton DC, Goodman KA, Malhotra NK, et al. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol. 2020 Aug 10;38(23):2677–94. doi: 10.1200/JCO.20.00866.
5. Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol, 2022 Jul 29. 33(10): 1005-1020. doi: 10.1016/j.annonc.2022.07.004.
6. Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, et al. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol, 2022 Oct. 33(10): 992-1004. doi: 10.1016/j.annonc.2022.07.003.
7. Dinh Ngoc Diep, Phan Tran Thien Nhan, Nguyen Le Quynh Nhu. status of gastric cancer parients before surgery at Binh Dan Hospital, 2022. Vn J Nutr Food, 2024 Oct 28, 20(5):79-84. doi: 10.56283/1859-0381/729.
8. Pham Duc Minh, Nguyen Thi Diu. Nutritional status, dietary intake and nutrition impact symptoms of cirrhotic patients. Vn J Nutri Food. 2023 Jun 28;19(3E):23-32. doi:10.56283/1859-0381/396.
9. Detry MA, Ma Y. Analyzing Repeated Measurements Using Mixed Models. JAMA. 2016 Jan 26;315(4):407-8. doi: 10.1001/jama.2015.19394.
10. Hebuterne, X., E. Lemarie, M. Michallet, et al., Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr, 2014. 38(2): 196-204. doi: 10.1177/0148607113502674.
11. Movahed S, Norouzy A, Ghanbari-Motlagh A, Eslami S, Khadem-Rezaiyan M, Emadzadeh M, et al. Nutritional Status in Patients with Esophageal Cancer Receiving Chemoradiation and Assessing the Efficacy of Usual Care for Nutritional Managements. Asian Pac J Cancer Prev, 2020 Aug 1. 21(8): 2315-2323. doi: 10.31557/APJCP.2020.21.8.2315.
12. Pham Van B, Nguyen Thi Thanh H, Le Thi H, Nguyen Le Tuan A, Dang Thi Thu H, Dang Viet D. Nutritional Status and Feeding Regimen of Patients with Esophagus Cancer-A Study from Vietnam. Healthcare (Basel), 2021 Mar 6. 9(3): 289. doi: 10.3390/healthcare9030289.
13. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol, 2011. 12(5): 489-95. doi: 10.1016/S1470-2045(10)70218-7.
14. Zhang L, Lu Y, and Fang Y. Nutritional status and related factors of patients with advanced gastrointestinal cancer. Br J Nutr, 2014 Jan 8. 111(7): 1239-44. doi: 10.1017/S000711451300367X.
15. Hill A, Kiss N, Hodgson B, Crowe TC, Walsh AD. Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr, 2011 Feb. 30(1): 92-8. doi: 10.1016/j.clnu.2010.07.015.